Skip to content
Subscriber Only

Martin Shkreli Sued Over Alleged Antitrust Violation in Drug Pricing

  • Vyera Pharmaceuticals, Kevin Mulleady also sued in New York
  • Shkreli is serving a seven-year sentence for unrelated crimes
Martin Shkreli outside federal court in Brooklyn, New York in 2017.
Martin Shkreli outside federal court in Brooklyn, New York in 2017.Photographer: Victor J. Blue/Bloomberg
Updated on

Convicted “Pharma Bro” Martin Shkreli was sued by federal officials and the state of New York for allegedly violating antitrust law when he jacked up the price of a crucial drug by 4,000% overnight in 2015.

The lawsuit was filed Monday in federal court in Manhattan by the Federal Trade Commission and New York Attorney General Letitia James. The complaint names Vyera Pharmaceuticals LLC, formerly known as Turing Pharmaceuticals, along with co-owners Shkreli and Kevin Mulleady.